BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37310337)

  • 1. Mindfulness-Oriented Recovery Enhancement remediates anhedonia in chronic opioid use by enhancing neurophysiological responses during savoring of natural rewards.
    Garland EL; Fix ST; Hudak JP; Bernat EM; Nakamura Y; Hanley AW; Donaldson GW; Marchand WR; Froeliger B
    Psychol Med; 2023 Apr; 53(5):2085-2094. PubMed ID: 37310337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement.
    Garland EL; Atchley RM; Hanley AW; Zubieta JK; Froeliger B
    Sci Adv; 2019 Oct; 5(10):eaax1569. PubMed ID: 31663023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: exploratory ERP findings from a pilot RCT.
    Garland EL; Froeliger B; Howard MO
    J Behav Med; 2015 Apr; 38(2):327-36. PubMed ID: 25385024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial.
    Garland EL; Nakamura Y; Bryan CJ; Hanley AW; Parisi A; Froeliger B; Marchand WR; Donaldson GW
    Am J Psychiatry; 2024 Feb; 181(2):125-134. PubMed ID: 38196335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial.
    Garland EL; Hanley AW; Nakamura Y; Barrett JW; Baker AK; Reese SE; Riquino MR; Froeliger B; Donaldson GW
    JAMA Intern Med; 2022 Apr; 182(4):407-417. PubMed ID: 35226053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Mindfulness-Oriented Recovery Enhancement on reward responsiveness and opioid cue-reactivity.
    Garland EL; Froeliger B; Howard MO
    Psychopharmacology (Berl); 2014 Aug; 231(16):3229-38. PubMed ID: 24595503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restructuring Hedonic Dysregulation in Chronic Pain and Prescription Opioid Misuse: Effects of Mindfulness-Oriented Recovery Enhancement on Responsiveness to Drug Cues and Natural Rewards.
    Garland EL; Howard MO; Zubieta JK; Froeliger B
    Psychother Psychosom; 2017; 86(2):111-112. PubMed ID: 28183077
    [No Abstract]   [Full Text] [Related]  

  • 9. Mindfulness-Oriented Recovery Enhancement reduces opioid craving, pain, and negative affect among chronic pain patients on long-term opioid therapy: An analysis of within- and between-person state effects.
    Parisi A; Hanley AW; Garland EL
    Behav Res Ther; 2022 May; 152():104066. PubMed ID: 35248875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity.
    Hanley AW; Garland EL
    Drug Alcohol Depend; 2020 Dec; 217():108351. PubMed ID: 33070057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being.
    Cooperman NA; Hanley AW; Kline A; Garland EL
    J Subst Abuse Treat; 2021 Aug; 127():108468. PubMed ID: 34134880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous theta stimulation during meditation predicts reduced opioid dosing following treatment with Mindfulness-Oriented Recovery Enhancement.
    Hudak J; Hanley AW; Marchand WR; Nakamura Y; Yabko B; Garland EL
    Neuropsychopharmacology; 2021 Mar; 46(4):836-843. PubMed ID: 32919401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain: A Randomized Clinical Trial.
    Cooperman NA; Lu SE; Hanley AW; Puvananayagam T; Dooley-Budsock P; Kline A; Garland EL
    JAMA Psychiatry; 2024 Apr; 81(4):338-346. PubMed ID: 38061786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients.
    Garland EL; Bryan CJ; Finan PH; Thomas EA; Priddy SE; Riquino MR; Howard MO
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S65-S72. PubMed ID: 28363322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing Natural Reward Responsiveness Among Opioid Users Predicts Chronic Pain Relief: EEG Analyses From a Trial of Mindfulness-Oriented Recovery Enhancement.
    Garland EL; Howard MO
    J Soc Social Work Res; 2018; 9(2):285-303. PubMed ID: 30854168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial.
    Garland EL; Hanley AW; Riquino MR; Reese SE; Baker AK; Salas K; Yack BP; Bedford CE; Bryan MA; Atchley R; Nakamura Y; Froeliger B; Howard MO
    J Consult Clin Psychol; 2019 Oct; 87(10):927-940. PubMed ID: 31556669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restructuring reward processing with Mindfulness-Oriented Recovery Enhancement: novel therapeutic mechanisms to remediate hedonic dysregulation in addiction, stress, and pain.
    Garland EL
    Ann N Y Acad Sci; 2016 Jun; 1373(1):25-37. PubMed ID: 27037786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness is Associated With Increased Hedonic Capacity Among Chronic Pain Patients Receiving Extended Opioid Pharmacotherapy.
    Thomas EA; Garland EL
    Clin J Pain; 2017 Feb; 33(2):166-173. PubMed ID: 28060783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial.
    Garland EL; Manusov EG; Froeliger B; Kelly A; Williams JM; Howard MO
    J Consult Clin Psychol; 2014 Jun; 82(3):448-459. PubMed ID: 24491075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mindfulness-oriented recovery enhancement reduces opioid dose in primary care by strengthening autonomic regulation during meditation.
    Garland EL; Hudak J; Hanley AW; Nakamura Y
    Am Psychol; 2020 Sep; 75(6):840-852. PubMed ID: 32915027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.